Patent US5116493A successfully refreshed from Google Patents.
US5116493A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Artificial pancreatic perfusion device with reseedable matrix
Assignee: Circe Biomedical Inc
•
Filing: 1991-03-25
•
Granted: 1992-05-26
•
Expires: 2011-03-25
Abstract
Abstract A device which serves as an artificial pancreas comprises a hollow fiber which is surrounded by islets of Langerhans enclosed in a housing. The islets are suspended in a semi-gel matrix or supporting material that is sufficiently viscous to physically support and maintain location of the islets about the hollow fiber, but sufficiently fluid to enable removal of the islet suspension from the device, followed by reseeding or replacement with fresh islet suspension. The matrix in which the islets are suspended preferably comprises calcium sodium alginate. The semi-gel supporting material also enables long term maintenance of islet cells in in vitro culture.
Inventors
- 👤 William L. Chick
- 👤 Randall G. Rupp
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-29 13:10
CPC Classifications
A; A61; A61L; A61L27/00; A61L27/02; A61L27/04; A61F; A61F2/00; A61F2/02; A61F2/022; A61L27/14; A61M; A61M1/00; A61M1/34; A61M1/3472; A61M1/3475; A61M1/14; A61M1/16; A61M1/1678
Claims Analysis
Total Claims: 22
Claim 1
Independent Claim
160 words
An artificial pancreatic perfusion device for providing insulin to an individual, the device comprising: a) a hollow fiber having one end connected to a blood vessel through a connecting means to receive blood from the individual and an opposite end connected to a blood vessel through a second connecting means to return blood to the individual, the hollow fiber having a porosity which selectively allows substances to pass transversely therethrough, such that blood flows within the hollow fiber, along the length of the fiber; and b) a housing containing a suspension of pancreatic islets of Langerhans, the suspension including pancreatic islets distributed in a supporting material about the hollow fiber such that the hollow fiber is surrounded by pancreatic islets along its length, the supporting material characterized by (i) being sufficiently viscous to maintain distribution of the islets with respect to the hollow fiber, and (ii) being sufficiently fluid to enable removal of the islet suspension for subsequent replacement thereof.
Claim 2
Dependent Claim
160 words
An artificial pancreatic perfusion device for providing insulin to an individual, the device comprising: a) a hollow fiber having one end connected to a blood vessel through a connecting means to receive blood from the individual and an opposite end connected to a blood vessel through a second connecting means to return blood to the individual, the hollow fiber having a porosity which selectively allows substances to pass transversely therethrough, such that blood flows within the hollow fiber, along the length of the fiber; and b) a housing containing a suspension of pancreatic islets of Langerhans, the suspension including pancreatic islets distributed in a supporting material about the hollow fiber such that the hollow fiber is surrounded by pancreatic islets along its length, the supporting material characterized by (i) being sufficiently viscous to maintain distribution of the islets with respect to the hollow fiber, and (ii) being sufficiently fluid to enable removal of the islet suspension for subsequent replacement thereof.
Claim 3
Dependent Claim
21 words
An artificial pancreatic perfusion device as in claim 1 wherein the islet suspension is removable from the housing by suction means.
Claim 4
Dependent Claim
26 words
An artificial pancreatic perfusion device as in claim 1, wherein the supporting medium has a viscosity of about 900 to about 1000 centipoises at 37° C.
Claim 5
Dependent Claim
17 words
An artificial pancreatic perfusion device as in claim 1 wherein the supporting material comprises calcium sodium alginate.
Claim 6
Dependent Claim
24 words
An artificial pancreatic perfusion device as in claim 1 wherein the islet suspension further includes at least one of collagen, laminin and growth factors.
Claim 7
Dependent Claim
94 words
In an artificial pancreatic perfusion device for providing insulin to an individual, the device comprising (i) a hollow fiber with a porosity that selectively allows substances to pass transversely therethrough and (ii) a housing containing a suspension of pancreatic islets of Langerhans about the hollow fiber, the improvement comprising: a matrix in which the islets are distributed and suspended to form an islet suspension, the matrix being sufficiently viscous to physically suspend and maintain the islets about the hollow fiber and sufficiently fluid to enable removal of the islet suspension for subsequent replacement thereof.
Claim 8
Dependent Claim
94 words
In an artificial pancreatic perfusion device for providing insulin to an individual, the device comprising (i) a hollow fiber with a porosity that selectively allows substances to pass transversely therethrough and (ii) a housing containing a suspension of pancreatic islets of Langerhans about the hollow fiber, the improvement comprising: a matrix in which the islets are distributed and suspended to form an islet suspension, the matrix being sufficiently viscous to physically suspend and maintain the islets about the hollow fiber and sufficiently fluid to enable removal of the islet suspension for subsequent replacement thereof.
Claim 9
Dependent Claim
15 words
An artificial pancreatic perfusion device as in claim 6 wherein the matrix is a semi-gel.
Claim 10
Dependent Claim
25 words
An artificial pancreatic perfusion device as in claim 6 wherein the matrix has a viscosity of about 900 to about 1000 centipoises at 37° C.
Claim 11
Dependent Claim
16 words
An artificial pancreatic perfusion device as in claim 6 wherein the matrix includes calcium sodium alginate.
Claim 12
Dependent Claim
33 words
An artificial pancreatic perfusion device as in claim 6 wherein the matrix maintains sufficient fluidity during use to enable removal of a portion of the islet suspension subsequent to a period of use.
Claim 13
Independent Claim
142 words
A method for seeding a device with islets of Langerhans on multiple occasions before and after use of the device for the production of insulin, comprising the steps of: (a) forming an islet suspension by distributing the islets in a supporting material sufficiently viscous to physically suspend the islets and sufficiently fluid to enable removal of the islet suspension from the device as desired; (b) introducing a first portion of islet suspension into the device, such first portion sufficient for the production of a desired amount of insulin by the device; (c) withdrawing some or all of said first portion of islet suspension from the device following a period of use of the device; and (d) introducing a second portion of islet suspension into the device, such second portion sufficient for the production of a desired amount of insulin by the device.
Claim 14
Independent Claim
142 words
A method for seeding a device with islets of Langerhans on multiple occasions before and after use of the device for the production of insulin, comprising the steps of: (a) forming an islet suspension by distributing the islets in a supporting material sufficiently viscous to physically suspend the islets and sufficiently fluid to enable removal of the islet suspension from the device as desired; (b) introducing a first portion of islet suspension into the device, such first portion sufficient for the production of a desired amount of insulin by the device; (c) withdrawing some or all of said first portion of islet suspension from the device following a period of use of the device; and (d) introducing a second portion of islet suspension into the device, such second portion sufficient for the production of a desired amount of insulin by the device.
Claim 15
Dependent Claim
67 words
A method for seeding as in claim 11 wherein the step of forming the islet suspension includes: (i) preparing an islet mixture comprising islets, supporting material and cell culture medium; (ii) maintaining said islet mixture in in vitro culture; and (iii) processing the islet mixture to obtain islet suspension for use in the steps of introducing the islet suspension into the device in steps (b) or (c).
Claim 16
Dependent Claim
21 words
A method for seeding as claimed in claim 12 wherein the islet mixture is maintained in culture at about 37° C.
Claim 17
Dependent Claim
51 words
A method for seeding as claimed in claim 12 wherein the islet mixture is processed to obtain islet suspension for introduction into the device by centrifuging such that a culture medium phase and an islet suspension phase are formed, and removing the culture medium phase to isolate the islet suspension phase.
Claim 18
Dependent Claim
17 words
A method of seeding as claimed in claim 11 wherein the device is an artificial pancreas device.
Claim 19
Independent Claim
104 words
A method of preparing islets of Langerhans for use in a device, comprising the steps of: (a) providing islets; (b) combining the islets with cell culture medium and a sufficient amount of a supporting material to form an islet mixture, the supporting material being sufficiently viscous to maintain suspension of the islets and sufficiently fluid to enable removal of the islet suspension from the device; (c) storing the islet mixture under in vitro culture conditions suitable for maintaining islets; and (d) forming a pipettable islet suspension phase from an amount of the islet mixture, by removing the cell culture medium from the islet mixture.
Claim 20
Independent Claim
104 words
A method of preparing islets of Langerhans for use in a device, comprising the steps of: (a) providing islets; (b) combining the islets with cell culture medium and a sufficient amount of a supporting material to form an islet mixture, the supporting material being sufficiently viscous to maintain suspension of the islets and sufficiently fluid to enable removal of the islet suspension from the device; (c) storing the islet mixture under in vitro culture conditions suitable for maintaining islets; and (d) forming a pipettable islet suspension phase from an amount of the islet mixture, by removing the cell culture medium from the islet mixture.
Claim 21
Dependent Claim
18 words
A method of preparing islets as claimed in claim 16 wherein the supporting material comprises calcium sodium alginate.
Claim 22
Dependent Claim
48 words
A method of preparing islets as claimed in claim 16 further comprising the steps of: removing islet mixture from in vitro culture; centrifuging the islet mixture to form a culture medium phase and an islet suspension phase; and isolating the islet suspension phase for use in the device.
References Cited (Backward Citations)
US3827565A
Cited
US3734851A
Cited
GB1479002A
Cited
US4323457A
Cited
FR2384504A1
Cited
US4169477A
Cited
US4242459A
Cited
US4242460A
Cited
US4378016A
Cited
EP0101373A1
Cited
US4578191A
Cited
EP0127989A2
Cited
WO1985005630A1
Cited
US5002661A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1995-05-26 | 1995-11-25 | 1996-05-26 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1999-05-26 | 1999-11-25 | 2000-05-26 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2003-05-26 | 2003-11-25 | 2004-05-26 | $7700.00 | Window Closed / Lapsed |